Cancer Registry of Norway Expands Study of Volpara in Breast Cancer Screening Programme
Incorporating Volumetric Breast Density and Imaging Performance Analytics in Quality Assurance Studies
Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening
Volpara Highlights Study that Shows Fully-Automated Volumetric Methods are Valid Alternatives to Measure Mammographic Breast Density and Predict Breast Cancer Risk
Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates VolparaDensity across Multiple Manufacturers
Researchers: Automated Measurement of Volumetric Mammographic Density is a Promising Tool for Widespread Breast Cancer Risk Assessment
Tomosynthesis Radiation Dose Varies Between Women According To Breast Density
Research Presented at AAPM by Volpara Solutions Questions Which Women Should be Considered for Breast Screening with Tomosynthesis Based on Reported Clinical Benefits and Patient-Specific Dose
Research Demonstrates Ability to Generate Patient Specific Mammographic Dose Using Volumetric Breast Density Data
Multiple Abstracts Accepted for Presentation at IWDM Demonstrate Benefit of Volumetric Breast Density, Patient Specific Dose and Breast Imaging Analytics Data from Volpara Solutions
Research Finds Use of Volpara Provides Actionable Intelligence for 2D and 3D Mammography Screening of Women with Dense Breasts
Seven Abstracts Accepted for Presentation at ECR Demonstrate Benefit of Volumetric Breast Care Imaging and Analytics Data
Europe-Wide Personalized Breast Cancer Screening Research Project to Use Volpara
ASSURE Research Project Will Use Volpara to Help Build a Model of Breast Cancer Risk and the Risk of Missing Cancers
Volpara Selected for Dutch Breast Screening MRI Trial
For Use with Digital Mammography, Volpara is Designed to Assist Radiologists by Providing Objective Breast Density Values
